ОбзорГрафикСвязанные символыНовости

CDAX-GESAMTINDEX (PERF)/  DE0008469602  

13.11.2024 17:50:00 Изменение -2.47 Открыть Максимум Минимум Предыдущее закрытие
1,637.64XXP -0.15% 1,640.11 1,648.06 1,624.36 1,640.11
TeleTrader 06.04.2017 VW teams up with Mobvoi for AI-assisted driving
GlobeNewswire 29.03.2017 Hawesko Holding AG: Dividend continuity
GlobeNewswire 31.01.2017 Hawesko Holding AG: Hawesko Holding slightly exceeds expectations
GlobeNewswire 12.01.2017 Hawesko Holding AG: Hawesko Group strengthens positioning in fine wine segment with ultra-premium sp...
GlobeNewswire 13.12.2016 MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...
GlobeNewswire 06.12.2016 MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...
GlobeNewswire 06.12.2016 MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016
GlobeNewswire 29.11.2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire 28.11.2016 MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...
GlobeNewswire 25.11.2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire 22.11.2016 Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect....
GlobeNewswire 21.11.2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire 21.11.2016 MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire 21.11.2016 MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire 17.11.2016 MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...
GlobeNewswire 17.11.2016 MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of...
GlobeNewswire 15.11.2016 MorphoSys Raises EUR 115 million in Private Placement
GlobeNewswire 15.11.2016 Ad hoc: MorphoSys Raises EUR 115 million in Private Placement
GlobeNewswire 15.11.2016 MorphoSys to Raise Capital via a Private Placement of New Shares
GlobeNewswire 15.11.2016 Ad hoc: MorphoSys to Raise Capital via a Private Placement of New Shares
GlobeNewswire 15.11.2016 MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in ...
GlobeNewswire 14.11.2016 Hawesko Holding AG: Raimund Hackenberger will become the new chief financial officer
GlobeNewswire 14.11.2016 MorphoSys to Present at Upcoming Investor Conferences
GlobeNewswire 08.11.2016 Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations
GlobeNewswire 07.11.2016 MorphoSys AG Reports Results for the First Nine Months of 2016